Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Adverse effects of tyrosine kinase inhibitors in cancer therapy: pathophysiology, mechanisms and clinical management
Sunitha Shyam Sunder, Umesh C. Sharma, Saraswati Pokharel
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 174

Showing 1-25 of 174 citing articles:

Potentials and future perspectives of multi-target drugs in cancer treatment: the next generation anti-cancer agents
Ali Doostmohammadi, Hossein Jooya, Kimia Ghorbanian, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 32
Therapeutic advances of targeting receptor tyrosine kinases in cancer
Ciprian Tomuleasa, Adrian Bogdan Țigu, Raluca Munteanu, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 21
Liquid biopsy for human cancer: cancer screening, monitoring, and treatment
Hao Wang, Yi Zhang, Hao Zhang, et al.
MedComm (2024) Vol. 5, Iss. 6
Open Access | Times Cited: 16
Journey of PROTAC: From Bench to Clinical Trial and Beyond
Kyli Berkley, Julian Zalejski, Nidhi Sharma, et al.
Biochemistry (2025)
Closed Access | Times Cited: 3
Theranostic Uses of the Heme Pathway in Neuro-Oncology: Protoporphyrin IX (PpIX) and Its Journey from Photodynamic Therapy (PDT) through Photodynamic Diagnosis (PDD) to Sonodynamic Therapy (SDT)
Stuart L. Marcus, Mark P. de Souza
Cancers (2024) Vol. 16, Iss. 4, pp. 740-740
Open Access | Times Cited: 10
Model-informed precision dosing: State of the art and future perspectives
Iris K. Minichmayr, Erwin Dreesen, Marco Centanni, et al.
Advanced Drug Delivery Reviews (2024) Vol. 215, pp. 115421-115421
Open Access | Times Cited: 10
A novel imatinib analogue inhibitor of chronic myeloid leukaemia: design, synthesis and characterization—explanation of its folded conformation
Rodolfo Moreno‐Fuquen, Juan F. Avellaneda-Tamayo, Kevin Arango-Daraviña, et al.
Royal Society Open Science (2025) Vol. 12, Iss. 1
Open Access | Times Cited: 1
PPIs effect in EGFR-TKI-associated interstitial lung diseases in patients with non-small cell lung cancer
Haitao Wang, Keyu Chen, Sai Ma, et al.
BMC Cancer (2025) Vol. 25, Iss. 1
Open Access | Times Cited: 1
Targeted Inhibitors of EGFR: Structure, Biology, Biomarkers, and Clinical Applications
Nina Shaban, Dmitri Kamashev, Aleksandra Emelianova, et al.
Cells (2023) Vol. 13, Iss. 1, pp. 47-47
Open Access | Times Cited: 17
Ferroptosis and circular RNAs: new horizons in cancer therapy.
Asif Ahmad Bhat, Neelima Kukreti, Muhammad Afzal, et al.
PubMed (2024) Vol. 23, pp. 570-599
Closed Access | Times Cited: 7
CAR-based immunotherapy for breast cancer: peculiarities, ongoing investigations, and future strategies
Zhipu Niu, Jingyuan Wu, Qiancheng Zhao, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 6
Molecular targeted therapies for cutaneous squamous cell carcinoma: recent developments and clinical implications.
H. B. Singh, Hitesh Chopra, Inderbir Singh, et al.
PubMed (2024) Vol. 23, pp. 300-334
Closed Access | Times Cited: 6
Comparison of PD-L1 (22C3) Expression in Paired Primary and Metastatic Breast Carcinoma
Xiao Huang, Sarah Anderson, Gene P. Siegal, et al.
Clinical Breast Cancer (2024) Vol. 24, Iss. 4, pp. e310-e318
Closed Access | Times Cited: 5
Tackling Non–Small Cell Lung Cancer in Young Adults: From Risk Factors and Genetic Susceptibility to Lung Cancer Profile and Outcomes
Juan Carlos Laguna, Marco Tagliamento, Matteo Lambertini, et al.
American Society of Clinical Oncology Educational Book (2024) Vol. 44, Iss. 3
Closed Access | Times Cited: 5
NTRK-fused central nervous system tumours: clinicopathological and genetic insights and response to TRK inhibitors
Eric Eunshik Kim, Chul-Kee Park, Seung-Ki Kim, et al.
Acta Neuropathologica Communications (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 4
First-Line Lenvatinib Plus Pembrolizumab Versus Chemotherapy for Advanced Endometrial Cancer: A Randomized, Open-Label, Phase III Trial
Christian Marth, Richard G. Moore, Mariusz Bidziński, et al.
Journal of Clinical Oncology (2024)
Closed Access | Times Cited: 4
Effect of Electric Fields on the Mechanical Mechanism of Regorafenib–VEGFR2 Interaction to Enhance Inhibition of Hepatocellular Carcinoma
Yichen Tian, Fenghui Liao, Heng Sun, et al.
Biomolecules (2025) Vol. 15, Iss. 1, pp. 42-42
Open Access
Thermal ablation included in multimodality treatment predicts enhanced survival in advanced non-small cell lung cancer: a propensity score-matched outcome study
Stella Chin‐Shaw Tsai, Yimin Chen, Yueh-Han Ku, et al.
International Journal of Hyperthermia (2025) Vol. 42, Iss. 1
Open Access
Risk Factors Analysis of Cutaneous Adverse Drug Reactions Caused by Targeted Therapy and Immunotherapy Drugs for Oncology and Establishment of a Prediction Model
Zimin Zhang, Mingyang Zhu, Weiwei Jiang
Clinical and Translational Science (2025) Vol. 18, Iss. 1
Open Access
Imaging Findings of Complications of New Anticancer Drugs
Ji Sung Jang, Hyo Jung Park, Chong Hyun Suh, et al.
Korean Journal of Radiology (2025) Vol. 26
Closed Access
Disrupted target binding with acryloyl group as potential Bcr-Abl/C-Src dual kinase inhibitor optimization strategies with maintained antitumor activity
Ching‐Fuh Lin, Hsin-Yi Chiang, Grace Shiahuy Chen, et al.
Bioorganic & Medicinal Chemistry Letters (2025) Vol. 119, pp. 130105-130105
Closed Access
The effect of healthcare professional-implemented interventions on adherence to oral targeted therapy in patients with cancer: a systematic review and meta-analysis
Fiona Angus, Wan-Chuen Liao, Victoria Adekoya, et al.
Supportive Care in Cancer (2025) Vol. 33, Iss. 2
Open Access
Design, Synthesis, and SAR of Covalent KIT and PDGFRA Inhibitors─Exploring Their Potential in Targeting GIST
Tom Schulz, Rajesh Gontla, Alina Teuber, et al.
Journal of Medicinal Chemistry (2025)
Closed Access
Insulin receptor tyrosine kinase substrate in health and disease (Review)
Xueyan Zhang, Zhewen Zhang
Molecular Medicine Reports (2025) Vol. 31, Iss. 3
Closed Access
Role of dasatinib in the management of lung cancer: A meta-analysis of clinical trials
Berun A. Abdalla, Rebaz Ali, Fahmi H. Kakamad, et al.
Biomedical Reports (2025) Vol. 22, Iss. 3
Open Access
Page 1 - Next Page

Scroll to top